다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Allarity Therapeutics Inc (ALLR)
Allarity Therapeutics Inc (ALLR) 뉴스

ALLR

Allarity Therapeutics (ALLR)

Allarity Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALLR

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	21:55	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/21	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/20	21:00	GlobeNewswire Inc.	Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/18	05:08	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/15	22:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/15	05:45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/15	05:01	GlobeNewswire Inc.	Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/10	00:21	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/09	22:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/09	05:05	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/07	22:30	GlobeNewswire Inc.	Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/06	22:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/06	22:13	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/06	21:00	GlobeNewswire Inc.	Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/05/02	21:00	GlobeNewswire Inc.	Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/04/29	20:00	GlobeNewswire Inc.	Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/04/17	22:10	GlobeNewswire Inc.	Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/04/04	22:15	GlobeNewswire Inc.	Allarity Therapeutics Announces 1-for-20 Reverse Stock Split	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/03/27	21:30	GlobeNewswire Inc.	Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/03/25	20:30	GlobeNewswire Inc.	Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/03/08	22:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/03/08	21:15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/03/08	21:15	GlobeNewswire Inc.	Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/03/08	11:45	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/03/05	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/03/01	23:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/02/28	20:00	GlobeNewswire Inc.	Allarity Therapeutics to Present at Biomarkers 2024	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/02/24	06:09	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/02/14	23:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLR	Allarity Therapeutics Inc
2024/02/03	07:03	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ALLR	Allarity Therapeutics Inc

검색 관련기사 보기:NASDAQ:ALLR

1 2 3 4 5 6 다음 >>

Vontobel Financial Produ...

Ishares Iv Plc Fallen An... (PK)

Invesco Raymond James SB...

Kingswood Acquisition

Sustainable Multi Asset ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관